Group sequential, sample size re‐estimation and two‐stage adaptive designs in clinical trials: a comparison
- 11 October 2005
- journal article
- editorial
- Published by Wiley in Statistics in Medicine
- Vol. 25 (6) , 933-941
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Two‐stage adaptive strategy for superiority and non‐inferiority hypotheses in active controlled clinical trialsStatistics in Medicine, 2004
- On the inefficiency of the adaptive design for monitoring clinical trialsBiometrika, 2003
- Sample Size Reestimation for Clinical Trials With Censored Survival DataJournal of the American Statistical Association, 2003
- Controlling type I error rate for fast track drug development programmesStatistics in Medicine, 2003
- A sample size adjustment procedure for clinical trials based on conditional powerBiostatistics, 2002
- Group sequential test strategies for superiority and non‐inferiority hypotheses in active controlled clinical trialsStatistics in Medicine, 2001
- Sample size re-estimation without unblinding for normally distributed outcomes with unknown varianceCommunications in Statistics - Theory and Methods, 1992
- The role of internal pilot studies in increasing the efficiency of clinical trialsStatistics in Medicine, 1990
- The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction1988
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983